MIPOMERSEN for Type iia hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 138 adverse event reports in the FDA FAERS database where MIPOMERSEN was used for Type iia hyperlipidaemia.
Most Reported Side Effects for MIPOMERSEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 67 | 33.7% | 1 | 4 |
| Hepatic enzyme increased | 48 | 24.1% | 0 | 5 |
| Injection site erythema | 48 | 24.1% | 1 | 3 |
| Influenza like illness | 36 | 18.1% | 0 | 3 |
| Injection site bruising | 31 | 15.6% | 0 | 3 |
| Fatigue | 26 | 13.1% | 0 | 2 |
| Nausea | 24 | 12.1% | 0 | 4 |
| Injection site discolouration | 23 | 11.6% | 1 | 1 |
| Injection site swelling | 23 | 11.6% | 0 | 0 |
| Injection site rash | 18 | 9.1% | 0 | 0 |
| Injection site reaction | 17 | 8.5% | 1 | 1 |
| Myalgia | 17 | 8.5% | 0 | 3 |
| Headache | 16 | 8.0% | 0 | 0 |
| Injection site pruritus | 15 | 7.5% | 0 | 1 |
| Drug dose omission | 14 | 7.0% | 1 | 1 |
Other Indications for MIPOMERSEN
Hypercholesterolaemia (23)
Product used for unknown indication (13)
Blood cholesterol increased (10)
Other Drugs Used for Type iia hyperlipidaemia
EVOLOCUMAB (5,556)
LOMITAPIDE (3,314)
ALIROCUMAB (1,913)
ATORVASTATIN (637)
EZETIMIBE (562)
ROSUVASTATIN (547)
INCLISIRAN (313)
SIMVASTATIN (294)
PRAVASTATIN (152)
JUXTAPID (145)